Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1/2 1

Status

Unknown 5

Sponsor Class

OTHER 5

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

CNS 5

Conditions

Glioma 5Brain Neoplasms 2Neuroblastoma 1Meningioma 1Glioblastoma 1Esthesioneuroblastoma, Olfactory 1

Interventions

Temozolomide 159Bevacizumab 69Radiotherapy 68Magnetic Resonance Spectroscopy 68Irinotecan 31Surgical Procedures, Operative 27Radiation 24Carboplatin 23Specimen Handling 20Carmustine 20Blood Specimen Collection 20Nivolumab 19Aminolevulinic Acid 18Biopsy 17Lomustine 16pembrolizumab 13Radiotherapy, Intensity-Modulated 13Cyclophosphamide 13trametinib 12fluorodopa F 18 12X-Rays 12Radiosurgery 12Erlotinib Hydrochloride 12Topotecan 11Everolimus 11Magnetic Resonance Imaging 10IL13-PE38 10dabrafenib 9Etoposide 9Drug Therapy 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Glioma × apatinib × CNS × Clear all
NCT04216550 2021-02-08

Prediction of Therapeutic Response of Apatinib in Recurrent Gliomas

The First Affiliated Hospital of Zhengzhou University

Unknown
600 enrolled
CNS

Glioma

NCT04588987 2020-10-19

Neoadjuvant Carilizumab and Apatinib for Recurrent High-Grade Glioma

Sun Yat-sen University

Phase 2 Unknown
60 enrolled
CNS

Glioma

NCT03741244 2019-07-23

TMZ Plus Apatinib in Newly Diagnosed High-grade Glioma:RCT

The Second Hospital of Hebei Medical University

Phase 2 Unknown
211 enrolled
CNS

Glioma

NCT03390062 2018-01-04

A Study of Apatinib in Recurrent or Recurrent High-grade Glioma

West China Hospital

Phase 2 Unknown
30 enrolled
CNS

Glioma

NCT02848794 2017-06-16

Apatinib and Irinotecan in Treating Patients With Recurrent High-grade Glioma

The First People's Hospital of Lianyungang

Phase 1/2 Unknown
40 enrolled
CNS

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡